Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flavio Forni

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Nanomedicine (London, England)|October 1, 2011
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery?Giovanni Tosi, Luca Badiali, Barbara Ruozi, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 3, 2015
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activityDaniela Belletti, Giovanni Tosi, Flavio Forni, et al.
Pharmaceutics|June 24, 2015
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA NanoparticlesAntonietta Vilella, Barbara Ruozi, Daniela Belletti, et al.
International Journal of Pharmaceutics|April 3, 2018
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brainDaniela Belletti, Andreas Martin Grabrucker, Francesca Pederzoli, et al.
Journal of Liposome Research|August 22, 2009
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cellsBarbara Ruozi, Monica Montanari, Eleonora Vighi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 10, 2013
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distributionAntonietta Vilella, Giovanni Tosi, Andreas M Grabrucker, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 24, 2018
Untargeted rat brain metabolomics after oral administration of a single high dose of cannabidiolCinzia Citti, Federica Palazzoli, Manuela Licata, et al.
International Journal of Pharmaceutics|June 3, 2014
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug releaseResham Chhabra, Andreas M Grabrucker, Patrizia Veratti, et al.
Molecular Neurobiology|June 26, 2015
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain InjuryBarbara Ruozi, Daniela Belletti, Hari S Sharma, et al.
Polymers|April 9, 2020
Investigating Novel Syntheses of a Series of Unique Hybrid PLGA-Chitosan Polymers for Potential Therapeutic Delivery ApplicationsJason Thomas Duskey, Cecilia Baraldi, Maria Cristina Gamberini, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Nanomedicine (London, England)|October 1, 2011
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery?Giovanni Tosi, Luca Badiali, Barbara Ruozi, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 3, 2015
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activityDaniela Belletti, Giovanni Tosi, Flavio Forni, et al.
Pharmaceutics|June 24, 2015
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA NanoparticlesAntonietta Vilella, Barbara Ruozi, Daniela Belletti, et al.
International Journal of Pharmaceutics|April 3, 2018
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brainDaniela Belletti, Andreas Martin Grabrucker, Francesca Pederzoli, et al.
Journal of Liposome Research|August 22, 2009
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cellsBarbara Ruozi, Monica Montanari, Eleonora Vighi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 10, 2013
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distributionAntonietta Vilella, Giovanni Tosi, Andreas M Grabrucker, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 24, 2018
Untargeted rat brain metabolomics after oral administration of a single high dose of cannabidiolCinzia Citti, Federica Palazzoli, Manuela Licata, et al.
International Journal of Pharmaceutics|June 3, 2014
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug releaseResham Chhabra, Andreas M Grabrucker, Patrizia Veratti, et al.
Molecular Neurobiology|June 26, 2015
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain InjuryBarbara Ruozi, Daniela Belletti, Hari S Sharma, et al.
Polymers|April 9, 2020
Investigating Novel Syntheses of a Series of Unique Hybrid PLGA-Chitosan Polymers for Potential Therapeutic Delivery ApplicationsJason Thomas Duskey, Cecilia Baraldi, Maria Cristina Gamberini, et al.
Pageof 7